Healthcare Analysts, along with KOL Physician Panel, discuss the recently-held 65th ASH Annual Meeting (relevant companies KURA JNJ GRCL BMEA SNDX APTO AFMD CRVS ALXO CRISon an Analyst/Industry conference call to be held on December 14 at 11 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on KURA:
- Kura Oncology’s Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society’s Pediatric Acute Leukemia (PedAL) Master Clinical Trial
- Kura Oncology announces clinical collaboration to evaluate ziftomenib
- Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
- Kura Oncology to Participate in the JMP Securities Hematology and Oncology Summit
- Oppenheimer biotechnology analyst to hold an analyst/industry conference call